Premium
Diabetic Pregnancy Managed with Intraperitoneal Insulin
Author(s) -
Fonseca V. A.,
Me R. K.,
O'Brien P. M. S.,
Fernando O. N.,
Stephen R.,
Dandona P.
Publication year - 1987
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/j.1464-5491.1987.tb00835.x
Subject(s) - medicine , pregnancy , caesarian section , insulin , diabetes mellitus , regimen , route of administration , surgery , endocrinology , genetics , biology
A woman with insulin‐dependent diabetes (IDDM) and resistance to subcutaneously injected insulin conceived while being treated with intraperitoneal (i.p.) insulin administered through a recently developed subcutaneous peritoneal access device (SPAD). She continued on this regimen during the pregnancy and at 37 weeks was delivered of a normal baby by Caesarian section. During her pregnancy, she had 2 episodes of infection of the SPAD, which were rapidly controlled by local instillation of antibiotics. Her diabetes remained under excellent control (HbA 1 : 7.3–7.5%) throughout her pregnancy. This case demonstrates that in such patients i.p. administration of insulin through a SPAD is a feasible mode of management during pregnancy.